NeoStem, Inc. (AMEX: NBS) today announced that it has been selected for the award “Best Stem Cell Company, 2010” in the New Economy’s Biotech Awards, which identify excellence in the field of technology. According to The New Economy's editor Jan Spiegel, who chaired the panel overseeing the awards, "Biotechnology is an exciting field, perhaps nowhere more so than in the area of adult stem cells. The building of NeoStem's adult stem cell platform and its leadership role in this field has been gaining increased recognition including from the Pontifical Council for Culture of the Vatican in the recently announced exclusive collaboration." Winners of the New Economy 2010 Awards have been selected based on criteria such as innovation, originality and quality of product, as well as proof of market development and excellence in client representation.
Robin Smith, NeoStem’s Chairman and CEO, will accept the award at a presentation and interview to be held at the London Stock Exchange on Thursday, July 8, 2010 at 11 am. "We are very pleased to be recognized by The New Economy as an industry leader in stem cells. NeoStem's VSEL(TM) technology represents the cornerstone of our R&D efforts to advance stem cell treatments in two of the world's largest pharmaceutical markets, US and China."
No comments:
Post a Comment